Comparison of two coronary risk equivalents: Diabetes mellitus and peripheral arterial disease;Risiken der koronaräquivalente diabetes mellitus und periphere arterielle verschlusskrankheit im vergleich

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 45, 2008, Pages 2317-2322

  Darius, H ^a   Trampisch, H J ^b   Pittrow, D ^c   Allenberg, J R ^d   Haberl, R L ^e   Mahn, M ^f   Tepohl, H G ^g   Burghaus, I ^b   Diehm, Curt ^h,i  

^a VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e Munich Municipal Hospital   (Germany)

^f Medizinische Abteilung   (Germany)

^g Klinikum Karlsbad Langensteinbach ^*

^h Klinikum Karlsbad Langensteinbach   (Germany)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Ankle brachial index; Cardiovascular risk; Coronary equivalent; Diabetes mellitus; Peripheral arterial disease; Screening; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; CLOPIDOGREL; HEMOGLOBIN A1C; INSULIN; STATIN;

ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; HUMAN; INTERMITTENT CLAUDICATION; RISK FACTOR; AGED; CARDIOVASCULAR DISEASE; FEMALE; GERMANY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PROSPECTIVE STUDY;

AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; GERMANY; HUMANS; MALE; PERIPHERAL VASCULAR DISEASES; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 55249091420     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1100921     Document Type: Article

References (30)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
2. Abbott RD, Brand FN, Kannel WB. Epidemiology of some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study. Am J Med 1990; 88: 376-81
3. Allenberg J, Trampisch H, Darius H et al. Prävalenz, Komorbidität und Behandlungsintensität der peripheren arteriellen Verschlusskrankheit in der Hausarztpraxis. Ergebnisse der getABI-Studie. Gefäßchirurgie 2004; 9: 166-171
4. American Diabetes Association. Peripheral Arterial Disease in People With Diabetes. Diabetes Care 2003; 26: 3333-3341
5. American Diabetes Association. Standards of Medical Care in Diabetes - 2007. Diabetes Care 2007; 30: S4-41
6. Arbeitsgruppe Epidemiologische Methoden der Deutschen Arbeitsgemeinschaft Epidemiologie (DAE). Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP). Internet: http:// www2.gsf.de:6666/gem/documents/GEP_DAE_0205.pdf. Zugriff am 23. Oktober 2008
7. Belch JJF, Topol EJ, Agnelli G et al. Critical Issues in Peripheral Arterial Disease Detection and Management: A Call to Action. Arch Intern Med 2003; 163: 884-892
8. Bhatt DL, Steg PG, Ohman EM et al. International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis. JAMA 2006; 295: 180-189
9. Diehm C, Lange S, Darius H et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006; 27: 1743-9
10. Diehm C, Schuster A, Allenberg JR et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172: 95-105
11. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 2005; 25: 1463-9
12. Dormandy J, Rutherford R. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31: S1-S296
13. getABI Study Group. getABI: German epidemiological trial on ankle brachial index for elderly patients in family practice to detect peripheral arterial disease, significant marker for high mortality. VASA 2002; 31: 241-248
14. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006; 114: 688-99
15. Greenland P, Abrams J, Aurigemma GP et al. Prevention Conference V. Beyond secondary prevention: Identifying the high-risk patient for primary prevention. Noninvasive tests of atherosclerotic burden. Circulation 2000; 101: E16-22
16. Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39
17. Haffner SM, Lehto S, Ronnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34
18. Heikkinen M, Salmenpera M, Lepantalo A et al. Diabetes care for patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 2007; 33: 583-91
19. Hirsch AT, Criqui MH, Treat-Jacobson D et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324
20. Hirsch AT, Haskal Z, Hertzer N et al. ACC/AHA Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). Circulation 2006; 113: 463-654
21. Holland-Letz T, Endres HG, Biedermann S et al. Reproducibility and reliability of the ankle-brachial index as assessed by vascular experts, family physicians and nurses. Vasc Med 2007; 12: 105-12
22. Lange S, Diehm C, Darius H et al. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes. Exp Clin Endocrinol Diabetes 2004; 112: 566-73
23. Leibson CL, Ransom JE, Olson W et al. Peripheral arterial disease, diabetes, and mortality. Diabetes Care 2004; 27: 2843-9
24. MacGregor AS, Price JF, Hau CM et al. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease - The Edinburgh Artery Study. Diabetes Care 1999; 22: 453-458
25. Norgren L, Hiatt W, Dormandy J et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33: S1-S75
26. Norman PE, Davis WA, Bruce DG et al. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2006; 29: 575-80
27. Ogren M, Hedblad B, Engstrom G et al. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Results from the population study 'Men born in 1914' from Malmo, Sweden. Eur J Vasc Endovasc Surg 2005; 29: 182-9
28. Pittrow D, Pieper L, Klotsche J, Wittchen HU. DETECT. Ergebnisse einer klinisch-epidemiologischen Querschnitts- und Verlaufsstudie mit 50.000 Patienten in 3.000 Hausarztpraxen. München: Elsevier, Oktober 2007
29. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996; 124: 136-45
30. Walters DP, Gatling W, Mullee MA et al. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med 1992; 9: 710-5